$36.59 0.47 (+1.30%)
11/20/2009 4:00 PM

Eli Lilly & Co. (LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Featured Broker Partners